Monopar Therapeutics

Monopar Therapeutics

  • Founded: 2014
  • Location: Wilmette, IL
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Chemoradiation-induced oral mucositis
  • Drug types: ORL, ONC, INF
  • Lead product: Validive
  • Product link: https://www.monopartx.com/pipeline/pipeline-chart
  • Funding: $9M IPO Dec 2019; $9M Nov 2019


monopartx.com

linkedin.com

job board


Short description:

Small Molecules

Drug notes:

Camsirubicin Clin1b soft tissue sarcoma; MNPR-101 RIT RD/Clin0 solid tumors, RD/Clin0 COVID-19; MNPR-101 RD/Clin0 solid tumors; MNPR-202 RD/Clin0 solid tumors

Long description:

Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing cancer therapeutics that either extend lives or improve patient quality of life. They aim to use their scientific and clinical expertise to reduce risk and accelerate clinical development of drug candidates. Monopar was founded in 2014 with current facilities located in San Francisco, CA and Chicago, IL.

Jobs:

Monopar Therapeutics
Clinical Project Manager
Wilmette, IL|15 days ago
Apply


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com